A leading cardiologist has cautioned that running marathons or maintaining an active lifestyle does not necessarily mean a ...

The drug, delivered by EMS as a single injection, improved infarct-related patency at cath lab arrival and 30-day clinical outcomes.

“Some arrhythmias can strike without warning and can be deadly especially in those who have underlying heart diseases such as ...

Patients with different subtypes of metabolic syndrome experience varying prevalence rates of stroke and ischemic heart disease.

Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug ...

Routine eye exams can reveal early signs of heart disease. Understand why eye screenings are considered valuable for early ...

Learn the signs of heart attack in women, how they differ from men’s, and why Black women face unique risks. Expert insight from cardiologist Dr. Jayne Morgan.

Results from the international VESALIUS-CV (TIMI 66) clinical trial found that among adults with atherosclerotic cardiovascular disease (ASCVD) or diabetes and no history of a prior heart attack or ...

Adding the PCSK9 inhibitor evolocumab to standard lipid-lowering therapy significantly reduced first major cardiovascular ...

The hazard ratio (HR) for the primary endpoint was (3.84, p = 0.0009) in the first month The Prolocor pFCG™ test has the ...

Satsuma Pharmaceuticals, Inc., a late-stage biopharmaceutical company and its corporate parent, Shin Nippon Biomedical ...

The estrogen deficit of perimenopause can also slow down your metabolism—an outcome of aging as well—and make you less ...